In vitro antigen presentation assay

Data will be available from in-vitro pre-clinical tests on the pharmacodynamic activity of the fusion vaccines.

This test will verify the capacity of the fusion vaccine to present certain tumour-antigen derived peptides corresponding to antigens present in the fused cancer cells.

BruCells has met with the Dutch MEB for a Scientific Advice Meeting on January 10, 2008 in The Hague.
The Dutch authorities consider that the proposed in-vitro pre-clinical tests are adequate to check the pharmacodynamic activity of the fusion vaccines and that no animal model tests would be necessary.

created over 14 years ago (24 February 2010)    last modified over 11 years ago (6 May 2013)   [ RDF ]   [ RelFinder ]